These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36758248)

  • 21. Apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol. Predictive value for CHD severity and prognostic utility in CHD patients.
    Liting P; Guoping L; Zhenyue C
    Herz; 2015 Mar; 40 Suppl 1():1-7. PubMed ID: 25374385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipoprotein (a): a risk factor for retinal vascular occlusion.
    Müller HM; Diekstall FF; Schmidt E; März W; Canzler H; Demeler U
    Ger J Ophthalmol; 1992; 1(5):338-41. PubMed ID: 1477637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ApoB/A1 and LDL-C/HDL-C and the prediction of cardiovascular risk in statin-treated patients.
    Liem AH; van de Woestijne AP; Roeters van Lennep HW; Zwinderman AH; van der Steeg WA; Jukema JW
    Curr Med Res Opin; 2008 Feb; 24(2):359-64. PubMed ID: 18081989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations of lipid measures with total occlusion in patients with established coronary artery disease: a cross-sectional study.
    Li T; Yuan D; Wang P; Jia S; Zhang C; Zhu P; Song Y; Tang X; Zhao X; Gao Z; Yang Y; Gao R; Xu B; Yuan J
    Lipids Health Dis; 2022 Nov; 21(1):118. PubMed ID: 36369093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein A1 is a stronger prognostic marker than are HDL and LDL cholesterol for cardiovascular disease and mortality in elderly men.
    Florvall G; Basu S; Larsson A
    J Gerontol A Biol Sci Med Sci; 2006 Dec; 61(12):1262-6. PubMed ID: 17234819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation of cholesterol and lipoprotein parameters with carotid artery plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) carotid MRI study.
    Virani SS; Catellier DJ; Pompeii LA; Nambi V; Hoogeveen RC; Wasserman BA; Coresh J; Mosley TH; Otvos JD; Sharrett AR; Boerwinkle E; Ballantyne CM
    Atherosclerosis; 2011 Dec; 219(2):596-602. PubMed ID: 21868017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia.
    Farnier M; Chen E; Johnson-Levonas AO; McCrary Sisk C; Mitchel YB
    Vasc Health Risk Manag; 2014; 10():279-90. PubMed ID: 24855368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gender-specific association of coronary artery calcium and lipoprotein parameters: the Heinz Nixdorf Recall Study.
    Erbel R; Lehmann N; Churzidse S; Möhlenkamp S; Moebus S; Mahabadi AA; Schmermund A; Stang A; Dragano N; Grönemeyer D; Seibel R; Kälsch H; Bauer M; Bröcker-Preuss M; Mann K; Jöckel KH;
    Atherosclerosis; 2013 Aug; 229(2):531-40. PubMed ID: 23701995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Spicy Food Consumption Frequency with Serum Lipid Profiles in Older People in China.
    Yu K; Xue Y; He T; Guan L; Zhao A; Zhang Y
    J Nutr Health Aging; 2018; 22(3):311-320. PubMed ID: 29484343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of subclinical atherosclerosis in retinal vein occlusion.
    Lyu M; Lee Y; Kim BS; Kim HJ; Hong R; Shin YU; Cho H; Shin JH
    Sci Rep; 2021 Jun; 11(1):11905. PubMed ID: 34099806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of ezetimibe, simvastatin and ezetimibe/simvastatin on correlations between apolipoprotein B, LDL cholesterol and non-HDL cholesterol in patients with primary hypercholesterolemia.
    Farnier M; Guyton JR; Jensen E; Polis AB; Johnson-Levonas AO; Brudi P
    Atherosclerosis; 2013 Aug; 229(2):415-22. PubMed ID: 23880197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol.
    Fonseca L; Paredes S; Ramos H; Oliveira JC; Palma I
    Lipids Health Dis; 2020 Jun; 19(1):127. PubMed ID: 32505210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low serum apolipoprotein A1/B ratio is associated with proliferative diabetic retinopathy in type 2 diabetes.
    Hu A; Luo Y; Li T; Guo X; Ding X; Zhu X; Wang X; Tang S
    Graefes Arch Clin Exp Ophthalmol; 2012 Jul; 250(7):957-62. PubMed ID: 22327732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive value of preoperative platelet-to-albumin ratio and apolipoprotein B-to-apolipoprotein A1 ratio for osteosarcoma in children and adolescents: a retrospective study of 118 cases.
    Ma C; Li R; Yu R; Guo J; Xu J; Yuan X; Guo J
    BMC Cancer; 2022 Jan; 22(1):113. PubMed ID: 35086516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
    Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD
    Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LDL-C/apoB and HDL-C/apoA-1 ratios predict incident chronic kidney disease in a large apparently healthy cohort.
    Bae JC; Han JM; Kwon S; Jee JH; Yu TY; Lee MK; Kim JH
    Atherosclerosis; 2016 Aug; 251():170-176. PubMed ID: 27341533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between lipids and apolipoproteins on type 2 diabetes risk; moderating effects of gender and polymorphisms; the ATTICA study.
    Mellor DD; Georgousopoulou EN; D'Cunha NM; Naumovski N; Chrysohoou C; Tousoulis D; Pitsavos C; Panagiotakos DB;
    Nutr Metab Cardiovasc Dis; 2020 May; 30(5):788-795. PubMed ID: 32127339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low HDL cholesterol levels in type I Gaucher disease do not lead to an increased risk of cardiovascular disease.
    de Fost M; Langeveld M; Franssen R; Hutten BA; Groener JE; de Groot E; Mannens MM; Bikker H; Aerts JM; Kastelein JJ; Hollak CE
    Atherosclerosis; 2009 May; 204(1):267-72. PubMed ID: 18842264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk Factors and Treatment Strategies in Patients With Retinal Vascular Occlusions.
    Chapin J; Carlson K; Christos PJ; DeSancho MT
    Clin Appl Thromb Hemost; 2015 Oct; 21(7):672-7. PubMed ID: 24335246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.